Article

A modular patient-derived organoid–xenograft platform reveals molecular and clinical trajectories of prostate cancer progression

2026-01-05

Abstract excerpt

Patient-derived organoids (PDOs) are becoming increasingly important in prostate cancer (PCa) translational research. However, direct proof-of-concept studies demonstrating their ability to model disease evolution, identify relevant biomarkers, and accurately predict treatment response in PCa patients, remain scarce. Here, we report the establishment of serially transplantable xenografts series derived from two ad...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 98887b9e-1323-55a7-8965-cd61cc8e20a4
DOI: 10.64898/2026.01.05.697006

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A modular patient-derived organoid–xenograft platform reveals molecular and clinical trajectories of prostate cancer progressionDOI 10.64898/2026.01.05.697006Read

Organoids: An Emerging Precision Medicine Model for Prostate Cancer ResearchSemantic proximity Read

ECM-free patient-derived organoids preserve diverse prostate cancer lineages and uncover <i>in vitro</i> -enriched cell typesSemantic proximity Read

A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening.Semantic proximity Read

Patient derived organoids to model rare prostate cancer phenotypes.Semantic proximity Read

Patient-derived xenografts and organoids model therapy response in prostate cancerSemantic proximity Read

The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.Semantic proximity Read

Patient-derived xenografts and organoids model therapy response in prostate cancer.Semantic proximity Read

Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor SignalingSemantic proximity Read

Prostate organoids: emerging experimental tools for translational research.Semantic proximity Read

An Integrated Preclinical Platform for Lethal Neuroendocrine Prostate Cancer from Rapid Autopsy Bone and Liver MetastasesSemantic proximity Read

Identifying drug sensitivity of multifocal primary prostate cancerSemantic proximity Read

Patient-derived prostate cancer organoids require α6-integrins for self-renewal and recapitulate genetic heterogeneity and histopathology of the original tumorsSemantic proximity Read